Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma

Cancer

Volumn 106, Issue 3, 2006, Pages 648-653

  Tanaka, Ryota ^a,b   Ishiyama, Tadashi ^b   Uchihara, Teruhito ^b,c   Inadome, Yukinori ^b   Iijima, Tatsuo ^b   Morishita, Yukio ^b   Kano, Junko ^b   Goya, Tomoyuki ^d   Noguchi, Masayuki ^b  

^a GUNMA PREFECTURAL CANCER CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d KYORIN UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bax; Bax inhibitor 1; Bcl 2; Bronchioloalveolar carcinoma; p53

Indexed keywords

BAX INHIBITOR 1 PROTEIN; INHIBITOR PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CONSERVATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOCARCINOMA; AGED; APOPTOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINS;

EID: 31544470384     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21639     Document Type: Article

References (11)

1. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med. 1993;329:690-694.
2. Rose CA, Richard WB, Mamoun Y, et al. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. Hum Pathol. 1997;28:1079-1082.
3. Xu Q, Reed JC. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell. 1998;1:337-346.
4. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001;61:5974-5978.
5. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
6. Schmits R, Cochlovius B, Treitz G, et al. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer. 2002;98:73-77.
7. Jean JC, Oakes SM, Joyce-Brady M. The Bax inhibitor-1 gene is differentially regulated in adult testis and developing lung by two alternative TATA-less promoters. Genomics. 1999;57: 201-208.
8. Mountain CF. Revisions in the international system for staging for lung cancer. Chest. 1997;111:1710-1717.
9. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. Berlin: Springer Verlag, 1999.
10. Travis WD, Brambilla E, Mulla-Hermelink HK, et al. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC, 2004.
11. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung-histologic characteristics and prognosis. Cancer. 1995;75:2844-2852.